Naltrexone pharmacotherapy for opioid dependent federal probationers

Journal of Substance Abuse Treatment

Volumn 14, Issue 6, 1997, Pages 529-534

  Cornish, James W ^a,b,d   Metzger, David ^a,b   Woody, George E ^a,b   Wilson, David ^c   McLellan, A Thomas ^a,b   Vandergrift, Barry ^a,b   O'Brien, Charles P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Eastern District of Pennsylvania   (United States)

^d Treatment Research Center   (United States)

Author keywords

Naltrexone; Opioid dependence; Parole; Probation; Substance dependence

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; CANNABIS; COCAINE; NALOXONE; NALTREXONE; OPIATE;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DEPENDENCE TREATMENT; DRUG URINE LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PATIENT COUNSELING; PRIORITY JOURNAL; PROBATION; URINALYSIS;

ADULT; COMBINED MODALITY THERAPY; COUNSELING; CRIMINAL LAW; FEMALE; FORENSIC PSYCHIATRY; HUMANS; MALE; NALTREXONE; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PATIENT DROPOUTS; RECURRENCE; SUBSTANCE ABUSE DETECTION; UNITED STATES;

EID: 0031467331     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(97)00020-2     Document Type: Article

References (23)

1. Alterman, A.I., McLellan, A.T., O'Brien, C.P., August, D.S., Snider, E.C., Cornish, J.W., Droba, M., Hall, C.P., Raphaelson, A., & Schrade, F. (1994). Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. Journal of Nervous and Mental Disorders, 182, 157-163.
2. Brahen, L.S., Capone, T., Heller, R.C., Linden, S.L., Landy, H.J., & Lewis, M.J. (1978). Controlled clinical study of naltrexone side effects comparing first-day doses and maintenance regimens. American Journal of Drug and Alcohol Abuse, 5, 235-245.
3. Brahen, L.S., Henderson, R.K., Capone, T., & Kordal, N. (1984). Naltrexone treatment in a jail work-release program. Journal of Clinical Psychiatry, 45, 49-52.
4. Carroll, K.M., Power, M.E., Bryant, K., & Rounsaville, B.J. (1993). One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome [see comments]. Journal of Nervous and Mental Disorders, 181(2), 71-79.
5. Gonzalez, J.P., & Brogden, R.N. (1988). Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 35, 192-213.
6. Greenstein, R.A., Arndt, I.C., McLellan, A.T., O'Brien, C.P., & Evans, B. (1984). Naltrexone: A clinical perspective. Journal of Clinical Psychiatry, 45(9 Pt 2), 25-28.
7. Greenstein, R.A., Evans, B.D., & McLellan, A.T. (1983). Predictors of favorable outcome following naltrexone treatment. Drug and Alcohol Dependence, 12, 173-180.
8. Hollister, L. (1978). Clinical evaluation of naltrexone treatment of opiate dependence: Report of the NRC Committee on clinical evaluation of narcotic antagonists. Archives of General Psychiatry, 35, 335-340.
9. Judson, B.A., Carney, T.M., & Goldstein, A. (1981). Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison. Drug Alcohol Dependence, 7, 325-346.
10. Judson, B.A., & Goldstein, A. (1984). Naltrexone treatment of heroin addiction: One-year follow-up. Drug Alcohol Dependence, 13, 357-365.
11. Kleber, H.D., & Kosten, T.R. (1984). Naltrexone induction: Psychologic and pharmacologic strategies. Journal of Clinical Psychiatry, 45, 29-38.
12. Lewis, D.C. (1975). The clinical usefulness of narcotic antagonists: Preliminary findings on the use of naltrexone. American Journal of Drug and Alcohol Abuse, 2, 403-415.
13. Lewis, D.C., Mayer, J., Hersch, R.G., & Black, R. (1978). Narcotic antagonist treatment: Clinical experience with naltrexone. International Journal of the Addictions, 13, 961-973.
14. Ling, W., & Wesson, D.R. (1984). Naltrexone treatment for addicted health-care professionals: A collaborative private practice experience. Journal of Clinical Psychiatry, 45, 46-48.
15. Martin, W.R. (1975). Treatment of heroin dependence with naltrexone. Current Psychiatric Therapies, 15, 157-161.
16. Martin, W.R., Jasinski, D.R., & Mansky, P.A. (1973). Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. Archives of General Psychiatry, 28, 784-791.
17. O'Brien, C.P., Greenstein, R.A., Mintz, J., & Woody, G.E. (1975). Clinical experience with naltrexone. American Journal of Drug and Alcohol Abuse, 2, 365-377.
18. O'Brien, C.P., Woody, G.E., & McLellan, A.T. (1986). A new tool in the treatment of impaired physicians. Philadelphia Medicine, 82(11), 442-446.
19. Rawson, R.A., Obert, J.L., McCann, M.J., & Ling, W. (1991). Psychological approaches for the treatment of cocaine dependence - A neurobehavioral approach. Journal of Addictive Diseases, 11(2), 97-119.
20. Schecter, A.J., Friedman, J.G., & Grossman, D.J. (1974). Clinical use of naltrexone (EN-1639A): Part I: Safety and efficacy in pilot studies. American Journal of Drug and Alcohol Abuse, 1, 253-269.
21. Shufman, E.N., Porat, S., Witztum, E., Gandacu, D., Bar-Hamburger, R., & Ginath, Y. (1994). The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry, 35, 935-945.
22. Tennant, F.S., Jr., Rawson, R.A., Cohen, A.J., & Mann, A. (1984). Clinical experience with naltrexone in suburban opioid addicts. Journal of Clinical Psychiatry, 45(9 Pt 2), 42-45.
23. Washton, A.M., Gold, M.S., & Pottash, A.C. (1984). Successful use of naltrexone in addicted physicans and business executives. Advances in Alcoholism and Substance Abuse, 4(2), 89-96.